NCT00932165View on ClinicalTrials.gov

Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

CompletedOBSERVATIONAL

Enrollment

451

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Breast Neoplasms

Interventions

DRUG

Exemestane

"Aromasin® Tablets 25mg, depending on the Investigator prescription. Frequency and duration are according to Package Insert as follows. The usual adult dose is 25 mg of exemestane administered orally once daily after a meal."